Practical Assessment of the Tradeoff between Fatal Bleeding and Coronary Thrombotic Risks using the Academic Research Consortium for High Bleeding Risk Criteria
-
Published:2021
Issue:
Volume:
Page:
-
ISSN:1340-3478
-
Container-title:Journal of Atherosclerosis and Thrombosis
-
language:en
-
Short-container-title:JAT
Author:
Sotomi Yohei1, Hikoso Shungo1, Nakatani Daisaku1, Dohi Tomoharu1, Mizuno Hiroya1, Okada Katsuki2, Kida Hirota1, Oeun Bolrathanak1, Sunaga Akihiro1, Sato Taiki1, Kitamura Tetsuhisa3, Sakata Yasuhiko4, Sato Hiroshi5, Hori Masatsugu6, Komuro Issei7, Sakata Yasushi1,
Affiliation:
1. Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine 2. Department of Transformative System for Medical Information, Osaka University Graduate School of Medicine 3. Division of Environmental Medicine and Population Sciences, Department of Social and Environmental Medicine, Graduate School of Medicine, Osaka University 4. Department of Clinical Medicine and Development and Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center 5. School of Human Welfare Studies Health Care Center and Clinic, Kwansei Gakuin University 6. Osaka International Cancer Institute 7. Department of Cardiovascular Medicine, University of Tokyo Graduate School of Medicine
Publisher
Japan Atherosclerosis Society
Subject
Biochemistry (medical),Cardiology and Cardiovascular Medicine,Internal Medicine
Reference27 articles.
1. 1) Urban P, Mehran R, Colleran R, Angiolillo DJ, Byrne RA, Capodanno D, Cuisset T, Cutlip D, Eerdmans P, Eikelboom J, Farb A, Gibson CM, Gregson J, Haude M, James SK, Kim HS, Kimura T, Konishi A, Laschinger J, Leon MB, Magee PFA, Mitsutake Y, Mylotte D, Pocock S, Price MJ, Rao SV, Spitzer E, Stockbridge N, Valgimigli M, Varenne O, Windhoevel U, Yeh RW, Krucoff MW and Morice MC: Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention. Circulation, 2019; 140: 240-261 2. 2) Cao D, Mehran R, Dangas G, Baber U, Sartori S, Chandiramani R, Stefanini GG, Angiolillo DJ, Capodanno D, Urban P, Morice MC, Krucoff M, Goel R, Roumeliotis A, Sweeny J, Sharma SK and Kini A: Validation of the Academic Research Consortium High Bleeding Risk Definition in Contemporary PCI Patients. J Am Coll Cardiol, 2020; 75: 2711-2722 3. 3) Nakamura M, Kadota K, Nakao K, Nakagawa Y, Shite J, Yokoi H, Kozuma K, Tanabe K, Iijima R, Harada A, Kuroda T and Murakami Y: High bleeding risk and clinical outcomes in East Asian patients undergoing percutaneous coronary intervention: the PENDULUM registry. EuroIntervention, 2021; 16: 1154-1162 4. 4) Ueki Y, Bar S, Losdat S, Otsuka T, Zanchin C, Zanchin T, Gragnano F, Gargiulo G, Siontis GCM, Praz F, Lanz J, Hunziker L, Stortecky S, Pilgrim T, Heg D, Valgimigli M, Windecker S and Raber L: Validation of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scores. EuroIntervention, 2020; 16: 371-379 5. 5) Watanabe H, Domei T, Morimoto T, Natsuaki M, Shiomi H, Toyota T, Ohya M, Suwa S, Takagi K, Nanasato M, Hata Y, Yagi M, Suematsu N, Yokomatsu T, Takamisawa I, Doi M, Noda T, Okayama H, Seino Y, Tada T, Sakamoto H, Hibi K, Abe M, Kawai K, Nakao K, Ando K, Tanabe K, Ikari Y, Hanaoka KI, Morino Y, Kozuma K, Kadota K, Furukawa Y, Nakagawa Y, Kimura T and investigators S-: Details on the effect of very short dual antiplatelet therapy after drug-eluting stent implantation in patients with high bleeding risk: insight from the STOPDAPT-2 trial. Cardiovasc Interv Ther, 2021; 36: 91-103
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|